Children

(414) 266-2000

Overall heart surgery outcomes

The Herma Heart Institute offers excellent outcomes for patients with surgical needs that range from routine to the most complex, as outlined in the graph that follows. Our program consistently outperforms when it comes to congenital heart surgery outcomes for even the most complex types of heart disease, as evaluated by the Society of Thoracic Surgeons.

 
 


complexity

 
Data shown is that most recently released by the Society for Thoracic Surgeons and is “risk adjusted,” meaning that it factors in how complex a surgery is, which may impact the risk to the patient. For hospitals like Children’s that treat the most complicated cases, risk adjustment allows a more realistic comparison of our outcomes (see blue bars) with hospitals operating at a similar level (see red bars) rather than those that care for more routine cases. Risk adjusting is based on internationally recognized methods (in this case, the Risk Adjustment for Congenital Heart Surgery, or RACHS-1 method), which group procedures into categories according to how complex they are.

  • A A A

    Text Size

  • Print Page

Our outcomes

Families worldwide trust the Herma Heart Institute for their child’s cardiac care. Learn the key quality and outcome measures that parents should look for in a heart program, and see how the Herma Heart Institute compares.

Help with travel

Traveling with a sick child to a new city can be stressful. Our Access Center can make your visit to our hospital as easy as possible.

Nationally recognized

 US News 2018-19 Heart

Among the nation's best

U.S. News & World Report has once again ranked the Herma Heart Institute at Children's Hospital of Wisconsin among the top programs in the nation for pediatric cardiology and heart surgery. This ranking reflects the excellent outcomes and care we provide for even the most complex heart conditions. Families travel from across the country, and even around the world, to receive care from our specialists who are experienced in treating congenital heart disease from before birth and into adulthood.